Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance. - Newell F; Pires da Silva I; Johansson PA; Menzies AM; Wilmott JS; Addala V; Carlino MS; Rizos H; Nones K; Edwards JJ; Lakis V; Kazakoff SH; et al. (Cancer cell, 2022)